Expiratory Muscle Strength Training in Improving Bulbar Function and Quality of Life in Patients With Head and Neck Cancer
The Impact of Expiratory Muscle Strength Training on Bulbar Function and Well Being of Individuals With Head and Neck Cancer
2 other identifiers
interventional
49
1 country
1
Brief Summary
This randomized clinical trial studies how well expiratory muscle strength training works in improving bulbar function and quality of life in patients with head and neck cancer. Expiratory muscle strength training may help to strengthen the muscles involved in breathing and swallowing and may allow improved breathing, airway safety, swallow function, and quality of life in patients with head and neck cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2016
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 29, 2016
CompletedFirst Submitted
Initial submission to the registry
June 1, 2017
CompletedFirst Posted
Study publicly available on registry
June 5, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 3, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 3, 2019
CompletedMay 21, 2019
May 1, 2019
2.3 years
June 1, 2017
May 17, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Airway safety during swallowing assessed using the Penetration-Aspiration Scale
Exploratory mixed effect model will be used to investigate swallow function with time (pre and 1, 3, 6, and 12 month post) as the within-subjects variable and group (expiratory muscle strength training and control) as the between-subjects variable. Pearson or Spearman correlation methods will be used to evaluate the relationship between swallow function/patterning and respiratory and swallow safety measures.
Up to 1 year
Secondary Outcomes (9)
Eating Assessment Tool-10
Up to 1 year
Expiratory flow assessed using portable digital peak flow meter
Up to 1 year
Functional Oral Intake Scale (FOIS)
Up to 1 year
Lingual strength defined as the maximum pressure of the tongue pressing against the hard palate measured using the Iowa Oral Performance Instrument
Up to 1 year
Maximum expiratory pressure assessed using the MicroRPM pressure meter
Up to 1 year
- +4 more secondary outcomes
Study Arms (2)
Arm I (standard of care, home exercises)
ACTIVE COMPARATORPatients receive standard of care comprising of written patient education materials focusing on oral care, signs/symptoms of dysphagia/aspiration, and trismus. Patients participate in a therapy session conducted by a speech pathologist over 30 minutes once per week for 6 weeks during chemoradiation therapy. Patients also perform prescribed exercises at home daily for 3 sets of 10 repetitions.
Arm II (standard of care, home exercises, EMST)
EXPERIMENTALPatients receive standard of care comprising of written patient education materials focusing on oral care, signs/symptoms of dysphagia/aspiration, and trismus. Patients participate in a therapy session conducted by a speech pathologist over 30 minutes once per week for 6 weeks during chemoradiation therapy. Patients perform prescribed exercises at home daily for 3 sets of 10 repetitions. Patients also participate in an EMST session over 30 minutes comprising of 5 sets of 5 repetitions daily for 5 days per week for 6 weeks during chemoradiation therapy
Interventions
Undergo therapy session conducted by a speech pathologist
Receive standard of care patient education materials focusing on oral care, signs/symptoms of dysphagia/aspiration, and trismus
Perform prescribed home exercises
Participate in EMST
Ancillary studies
Ancillary studies
Eligibility Criteria
You may qualify if:
- Patients with a definitive, curative treatment plan consisting of chemoradiation for head \& neck cancer
- Surgery, if required, must be limited to: diagnostic biopsy
You may not qualify if:
- Participants enrolled in a radiation de-intensification protocol
- Current or previous neurological disease, which may adversely affect swallowing
- History of oropharyngeal swallowing disorder prior to cancer diagnosis
- Previous neurosurgery on the brain
- Severe chronic obstructive pulmonary disease (COPD) requiring oxygen dependence, as this is a contraindication of EMST
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Loni Arrese, PhD, SLP
Ohio State University Comprehensive Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 1, 2017
First Posted
June 5, 2017
Study Start
September 29, 2016
Primary Completion
January 3, 2019
Study Completion
January 3, 2019
Last Updated
May 21, 2019
Record last verified: 2019-05